Immune thrombocytopenia (ITP): vizsgálatok itt: Németország
14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Where
- Berlin, Dresden, Essen, Frankfurt Am Main, Giessen, Jena, Leipzig
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07007962 · EU 2025-522070-36-00 - 1/2. fázisNot yet taking people in NémetországAn Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1
- Where
- Tuebingen
- Életkor
- 18 év to 80 év
- People
- 36
- Run by
- University Hospital Tuebingen
See details and how to joinNCT07932262 · EU 2024-519491-60-00 - 3. fázisTaking peopleA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Essen, Jena, Mannheim
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - 1. fázisTaking peoplePhase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
- Where
- Dresden, Erlangen, Goettingen, Luebeck, Rüdersdorf, Tuebingen
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00 - 3. fázisTaking peopleA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Essen, Jena, Mannheim
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00 - 3. fázisTaking peopleA Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- Where
- Frankfurt Am Main
- Életkor
- 18 év to 70 év
- People
- 40 worldwide
- Run by
- Kedrion S.p.A.
See details and how to joinNCT07059000 · EU 2023-507115-35-00 - 1/2. fázisTaking peopleSafety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
- Where
- Cologne, Dresden, Hanover, Mainz
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07549698 - 2/3. fázisTaking peopleA Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
- Where
- Berlin, Cologne, Freiburg im Breisgau, Heidelberg
- Életkor
- 12 év to 17 év
- People
- 24 worldwide
- Run by
- argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00 - 2. fázisNot yet taking people in NémetországStudy of Zola-cel (BMS-986353), CD19 NEX-T CAR T Cells in Autoimmune Cytopenia (Breakfree-AiCE)
- Where
- Erlangen, Magdeburg
- Életkor
- 18 év and over
- People
- 3 worldwide
- Run by
- Celgene Corp.
See details and how to join2025-524993-41-00 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Dresden, Erlangen, Goettingen, Rüdersdorf, Tuebingen
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 1. fázisCsak meghívásosPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Erlangen, Göttingen, Lübeck, Sachsen, Tübingen
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - 2. fázisNot yet taking people in NémetországStudy of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
- Where
- Erlangen, Magdeburg
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07603557 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Where
- Dresden, Essen
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00 - No phaseTaking peopleITP Registry and Accompanying Biospecimen Collection
- Where
- Aachen, Altenburg, Aschaffenburg, Bad Homburg, Bad Liebenwerda, Berlin, Biberach, Bochum, Chemnitz, Coburg, Darmstadt, Donauwörth, Dresden, Düren, Erfurt, Erlangen, Essen, Frankfurt am Main, Frechen, Garbsen, Gera, Göppingen, Greifswald, Hagen, Halle, Hamburg, Hanover, Heidenheim, Hildesheim, Idar-Oberstein, Jena, Kassel, Kiel, Koblenz, Kronach, Leer, Leipzig, Magdeburg, Merseburg, München, Neubrandenburg, Neustadt am Rübenberge, Offenburg, Riesa, Rostock, Schkeuditz, Schwetzingen, Soest, Ulm, Villingen-Schwenningen, Wolfsburg, Würzburg, Zittau
- Életkor
- 18 év and over
- People
- 1100
- Run by
- Jena University Hospital
See details and how to joinNCT05152238